VENTIRX PHARMACEUTICALS

ventirx-pharmaceuticals-logo

VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of medicines for the treatment of cancer, and respiratory and autoimmune diseases. The company focuses on the development of small molecule product candidates targeting toll-like receptor 8 (TLR8) agonists and antagonists. Its product pipeline comprises VTX-2337, a small molecule TLR8 agonist that stimulates myeloid dendritic cells and monocytes, and enhances natural killer... cell responses for the treatment of solid tumors, ovarian and breast cancers, and NHL and SCHN; VTX-1463, a stand alone agent for the treatment of seasonal and perennial allergies; TLR8 antagonists for the treatment of autoimmune diseases; and multiple compounds that are treated as vaccine adjuvants. The company has a strategic agreement/collaboration with Celgene Corporation. VentiRx Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Seattle, Washington with operations in San Diego.

#People #Financial #Website #More

VENTIRX PHARMACEUTICALS

Industry:
Biotechnology Health Care Therapeutics

Founded:
2006-01-01

Address:
Seattle, Washington, United States

Country:
United States

Website Url:
http://www.ventirx.com

Total Employee:
11+

Status:
Active

Contact:
(206) 689-2259

Email Addresses:
[email protected]

Total Funding:
104.5 M USD

Technology used in webpage:
GStatic Google Static Content Proofpoint CSC Global DNS



Current Advisors List

nicole-vitullo_image

Nicole Vitullo Board of Directors @ VentiRx Pharmaceuticals
Board_member

kent-snyder_image

Kent Snyder Board Director @ VentiRx Pharmaceuticals
Board_member

patrick-heron_image

Patrick Heron Board Director @ VentiRx Pharmaceuticals
Board_member

atul-saran_image

Atul Saran Board Director @ VentiRx Pharmaceuticals
Board_member

elliott-grossbard_image

Elliott Grossbard Board Director @ VentiRx Pharmaceuticals
Board_member

steven-gillis_image

Steven Gillis Chairman of the Board of Directors @ VentiRx Pharmaceuticals
Board_member

Current Employees Featured

robert-m-hershberg_image

Robert M. Hershberg
Robert M. Hershberg CEO & Board Member @ VentiRx Pharmaceuticals
CEO & Board Member
2012-09-01

gregory-n-dietsch_image

Gregory N. Dietsch
Gregory N. Dietsch VP of Research @ VentiRx Pharmaceuticals
VP of Research
2006-01-01

kathleen-fanning_image

Kathleen Fanning
Kathleen Fanning VP, Business Development & Alliance Management @ VentiRx Pharmaceuticals
VP, Business Development & Alliance Management
2012-01-01

elliott-grossbard_image

Elliott Grossbard
Elliott Grossbard Director @ VentiRx Pharmaceuticals
Director

gregory-n-dietsch_image

Gregory N. Dietsch
Gregory N. Dietsch Vice President of Research @ VentiRx Pharmaceuticals
Vice President of Research
2007-01-01

Founder


michael-j-kamdar_image

Michael J. Kamdar

robert-m-hershberg_image

Robert M. Hershberg

Investors List

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series B - VentiRx Pharmaceuticals

medimmune-ventures_image

MedImmune Ventures

MedImmune Ventures investment in Series B - VentiRx Pharmaceuticals

celgene_image

Celgene

Celgene investment in Series B - VentiRx Pharmaceuticals

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series B - VentiRx Pharmaceuticals

domain-associates_image

Domain Associates

Domain Associates investment in Series B - VentiRx Pharmaceuticals

domain-associates_image

Domain Associates

Domain Associates investment in Series A - VentiRx Pharmaceuticals

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series A - VentiRx Pharmaceuticals

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series A - VentiRx Pharmaceuticals

medimmune-ventures_image

MedImmune Ventures

MedImmune Ventures investment in Series A - VentiRx Pharmaceuticals

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series A - VentiRx Pharmaceuticals

Official Site Inspections

http://www.ventirx.com

  • Host name: 165.160.13.20
  • IP address: 165.160.13.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "VentiRx Pharmaceuticals" on Search Engine